The Current Ratio as of November 2024 (TTM) for Annexon, Inc. (ANNX) is 21.81

According to Annexon, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 21.81. This represents a change of 30.21% compared to the average of 16.75 of the last 4 quarters.

Annexon, Inc. (ANNX) Historical Current Ratio (quarterly & annually)

How has ANNX Current Ratio performed in the past?

The mean historical Current Ratio of Annexon, Inc. over the last ten years is 13.59. The current 21.81 Current Ratio has changed 15.94% with respect to the historical average. Over the past ten years (40 quarters), ANNX's Current Ratio was at its highest in in the September 2020 quarter at 41.56. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Annexon, Inc. (ANNX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Annexon, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Annexon, Inc. (ANNX) Average Current Ratio

How has ANNX Current Ratio performed in the past?

The current Current Ratio of Annexon, Inc. (ANNX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Annexon, Inc. (ANNX) Current Ratio vs. Peers

How is ANNX’s Current Ratio compared to its peers?

Annexon, Inc.’s Current Ratio is greater than Immix Biopharma, Inc. (7.00), greater than CNS Pharmaceuticals, Inc. (0.31), greater than Hepion Pharmaceuticals, Inc. (5.62), greater than Freeline Therapeutics Holdings plc (1.95), less than AVROBIO, Inc. (26.17), greater than Day One Biopharmaceuticals, Inc. (14.62), greater than Acumen Pharmaceuticals, Inc. (17.37), greater than X4 Pharmaceuticals, Inc. (6.07), greater than Inozyme Pharma, Inc. (9.84), greater than VectivBio Holding AG (9.14), greater than IVERIC bio, Inc. (15.53), greater than Blueprint Medicines Corporation (3.32), greater than Amylyx Pharmaceuticals, Inc. (4.66), greater than Karuna Therapeutics, Inc. (19.31), greater than Arcus Biosciences, Inc. (5.14), less than Cullinan Oncology, Inc. (28.87), less than Structure Therapeutics Inc. (41.38), greater than Relay Therapeutics, Inc. (15.64), greater than Zura Bio Limited (12.57), greater than Icosavax, Inc. (18.06), greater than IN8bio, Inc. (2.66), greater than Wave Life Sciences Ltd. (0.99),

Build a custom stock screener for Annexon, Inc. (ANNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Annexon, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Annexon, Inc. (ANNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Annexon, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.